BrainCheck, Inc.

BrainCheck Inc. is a digital health company dedicated to advancing cognitive assessment and care. The company's core mission is to usher in a new era for brain health by integrating cognitive health into routine annual wellness visits, thereby bridging the gap between the prevalence of cognitive impairment and its early detection. Headquartered in Austin, Texas, BrainCheck also maintains an office in New York City.

The company offers a comprehensive digital platform featuring BrainCheck Assess™, an FDA Class II medical device for digital cognitive assessment, BrainCheck Screen™ for initial evaluations, and BrainCheck Plan™ for developing personalized care strategies. These tools are designed to identify subtle signs of cognitive impairment, potentially linked to conditions such as Alzheimer's disease, and to facilitate ongoing cognitive care. The platform is compatible with electronic health record (EHR) systems and is utilized by healthcare professionals in primary care, neurology, geriatrics, behavioral health, and academic research environments.

BrainCheck has recently expanded its financial backing, securing an additional $13 million in Series A financing in February 2026, contributing to a total funding of approximately $58.15 million. The platform is currently employed by over 500 healthcare organizations across the United States, with more than 640,000 cognitive assessments completed to date. Recent leadership appointments include Dr. Stephen Bekanich as Chief Medical Officer in March 2026 and Steve Wardle as President in July 2025, under the leadership of CEO Chris J. Loughlin. The company is strategically focused on enhancing its AI-assisted clinical infrastructure and expanding its presence within value-based care models.